Hrushikesh Vyas / LinkedIn
Jul 17, 2026, 09:57
Hrushikesh Vyas: Presenting Inherited Thrombocytopenia Research at ISTH 2026
Hrushikesh Vyas, CRUK Clinical Research Training Fellow, Haematology Doctor – ST4, shared a post on LinkedIn:
“Had a wonderful time at International Society on Thrombosis and Haemostasis (ISTH) congress in Paris learning and engaging with experts from the field of haemostasis and thrombosis.
It was a great experience to present our work on the use of dasatinib as a novel treatment for SRC-Related Thrombocytopenia in the session on the clinical implications of inherited thrombocytopenias. Thank you to all those that attended and engaged!
Thank you to my supervisors Prof Neil Morgan, Dr Gillian Lowe and Dr Manoj Raghavan for their support and guidance.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 03:07Luke McLaughlin: The First Community Article of the Haemophilia Rights Project
-
Sep 5, 2026, 03:00Panagiotis Christoforou: Proud to Contribute to Barts Health’s Leading Role in UK Clinical Trials
-
Sep 5, 2026, 02:51Kassiani Maria Nastouli: Honored to Be Cited in the New ESC Guidelines on the Management of CVD and CKD
-
Sep 5, 2026, 02:44Sedat Gül: Is It Time to Reconsider the 24-Hour Antiplatelet Delay After Thrombolysis?
-
Sep 5, 2026, 02:35Balaji Balagani: Exploring Stable vs Unstable vs Complete Coronary Block
-
Sep 5, 2026, 02:28N. Mariana S. Vasquez: Warm vs Cold Autoimmune Hemolytic Anemia for USMLE/NBME Questions
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism